Immunovia announces financial calendar for financial year 2024
LUND, SWEDEN – Immunovia, a diagnostic company with the vision to revolutionize blood-based diagnostics and survival rates for patients with cancer, announces its financial calendar for 2024. Year-End 2023 Report February 21, 2024 Annual Report to be published March 15, 2024 Q1 Report, 2024 April 25, 2024 Q2 Report, 2024 August 22, 2024 Q3 Report, 2024 November 14, 2024 The Annual General Meeting will be held on April 25, 2024, 15:00-16:00 CET. For more information, please contact: Karin Almqvist